RADIATION THERAPY (RT) AND TEMOZOLAMIDE (TMZ) AS ADJUVANT THERAPY IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM). PRELIMINARY DATA

被引：0
|
作者：
Iodice, G. [1 ]
Fusco, V. [2 ]
Tartarone, A. [1 ]
Bochicchio, A. M. [1 ]
Capobianco, A. [1 ]
Coccaro, M. R. [1 ]
Di Leo, P. [1 ]
Romano, G. P. [1 ]
Castaldo, G. [2 ]
Montagna, A. [2 ]
Lapadula, L. [2 ]
机构：
[1] Ctr Riferimento Oncol, Hematol Oncol Unit, Rionero In Vulture, PZ, Italy
[2] Ctr Riferimento Oncol, Radiotherapy Unit, Rionero In Vulture, PZ, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：87 / 87
页数：1
相关论文
共 50 条
  • [41] The Addition of Bevacizumab (BEV) to Temozolomide (TMZ) and Radiation Therapy (RT) in Newly Diagnosed Glioblastoma (GBM) Improves Progression-Free Survival (PFS) Without Adding to RT Toxicity
    Saran, F.
    Henriksson, R.
    Mason, W.
    Wick, W.
    Nishikawa, R.
    Cloughesy, T.
    Hilton, M.
    Kerloeguen, Y.
    Chinot, O. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S16 - S16
  • [42] Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme
    Briceno, Eduardo
    Calderon, Alejandra
    Sotelo, Julio
    SURGICAL NEUROLOGY, 2007, 67 (04): : 388 - 391
  • [43] Hypofractionated radiation therapy with temozolomide versus standard chemoradiation in patients with glioblastoma multiforme (GBM): A prospective, single institution experience
    Rayan, Amal
    Abdel-Kareem, Samya
    Hasan, Huda
    Zahran, Asmaa M.
    Gamal, Doaa A.
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2020, 25 (06) : 890 - 898
  • [44] The Impact of Surgery on the Efficacy of Adjuvant Therapy in Glioblastoma Multiforme
    Brzozowska, Anna
    Torun, Anna
    Mazurkiewicz, Maria
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 24 (02): : 279 - 287
  • [45] NABTT 0306: A randomized phase II trial of EMD 121974 in conjunction with concomitant and adjuvant temozolomide with radiation therapy in patients with newly diagnosed glioblastoma multiforme (GBM)
    Nabors, L. B.
    Mikkelsen, T.
    Batchelor, T.
    Lesser, G.
    Rosenfeld, M.
    Ye, X.
    Piantadosi, S.
    Olson, J.
    Brem, S.
    Grossman, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] THE EFFECT OF TIMING OF RADIOTHERAPY (RT) IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) RECEIVING TEMOZOLOMIDE (TMZ): AN ANALYSIS BASED ON THE UCSF EXPERIENCE
    Han, S. J.
    Rutledge, W. C.
    Molinaro, A. M.
    Chang, S.
    Clarke, J. L.
    Prados, M. D.
    Berger, M. S.
    Butowski, N. A.
    NEURO-ONCOLOGY, 2014, 16
  • [47] THE EFFECT OF DELAYING RADIOTHERAPY (RT) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) RECEIVING TEMOZOLOMIDE (TMZ): A SECONDARY ANALYSIS BASED ON THE UCSF EXPERIENCE
    Butowski, Nicholas A.
    Polley, Mei-Yin C.
    Lamborn, Kathleen L.
    Chang, Susan
    Prados, Michael
    Clarke, Jennifer L.
    Huang, Kim
    Sneed, Patricia
    NEURO-ONCOLOGY, 2009, 11 (05) : 665 - 665
  • [48] Role of radiation therapy and radiosurgery in glioblastoma multiforme
    Fiveash, JB
    Spencer, SA
    CANCER JOURNAL, 2003, 9 (03): : 222 - 229
  • [49] Combination of temozolomide (TMZ) and radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase II study
    Athanassiou, H
    Synodinou, M
    Maragoudakis, E
    Paraskevaidis, M
    Verigos, C
    Misailidou, D
    Antonadou, D
    Sarris, G
    Beroukas, K
    Karageorgis, P
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S162 - S163
  • [50] A Phase 2 Trial of Hypofractionated-Intensity Modulated Radiation Therapy (Hypo-IMRT) Combined With Temozolomide (TMZ) and Bevacizumab (BEV) for Patients With Newly Diagnosed Glioblastoma Multiforme (GBM)
    Carlson, J. A.
    Ney, D.
    Reddy, K.
    Gaspar, L. E.
    Kavanagh, B. D.
    Damek, D.
    Lillehei, K. O.
    Chen, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S284 - S285
12345